Tilray Brands, Inc.

NASDAQ:TLRY

Drug Manufacturers - Specialty & Generic

Healthcare
$2.25 -0.84%

-$0.04 today

Market cap
$251.62M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $3.50High $23.20

Volume 5.03M

Average 4.73M

TLRY Debt Repayment

Cash used to repay borrowings during the period.

Tilray Brands, Inc.NASDAQ: TLRY

Debt Repayment · Q3 FY2026 · quarter ended Feb 2026

Debt repayment declines year over year

Q3 FY2026 debt repayment of $4.05M (cash outflow) fell 67.8% year over year, behind the -37.8% change in trailing-twelve-month debt repayment. Sequentially, it fell 40.0% from the prior quarter. Over 3 fiscal years it compounded at -40.3% a year.

Context

  • Debt repayment amounted to 2.8% of revenue in FY2025, down 7.4 pp from a year earlier.
  • Debt repayment grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -67.8% toward the trailing-twelve-month pace of -37.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterFeb 2026
-$4.05M-40.0% QoQ
Last fiscal yearMay 2025
-$31.89M-71.1% YoY
LTMFeb 2026
-$17.69M-37.8% YoY
Debt Repayment past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-67.8%——
1 year-71.1%——
3-year CAGR-40.3%——
5-year CAGR——
10-year CAGR——

Debt Repayment history

USD · from the cash flow

Latest · FY2025
(31.89M) USD
Year-over-year change
+71.1%

Debt Repayment vs competitors

How TLRY compares with its peers on the latest reported figures

  • Peers report in different currencies, so debt repayment is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -37.8% is the lowest of 3, against a peer median of +219.7%.
  • Debt repayment amounts to 1.5% of revenue for TLRY, versus a peer median of 2.9%.
TLRY Competitors
Debt Repayment for TLRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNDLSNDL Inc.LTM Mar 2026CA$41.79M CAD+13.1%+1.4%4.5%
TLRYTilray Brands, Inc.LTM Feb 2026$17.69M USD-37.8%-40.3%1.5%
ACBAurora Cannabis Inc.LTM Mar 2026CA$4.24M CAD+426.3%—1.4%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY) —+219.7%+1.4%2.9%

Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Net Income(443.62M)(601.05M)(1.96B)(333.8M)(3B)
Depreciation & Amortization81.9M194.88M175.31M172.93M183.17M
Deferred Income Tax(30.03M)(34.71M)(43.04M)(52.97M)(166.06M)
Stock-Based Compensation00000
Change in Working Capital(61.5M)(115.68M)19.4M(12.09M)(85.85M)
Accounts Receivables(28.39M)(7.36M)5.61M(8.96M)(24.43M)
Inventory(42.6M)(57.67M)(17.42M)(21.23M)(18.61M)
Accounts Payables17.51M(56.29M)27M288.86K(31.48M)
Other Working Capital(8.01M)5.64M4.21M17.81M(11.34M)
Other Non-Cash Items399.26M333.12M1.82B183.82M2.94B
Operating Cash Flow(53.99M)(223.45M)10.65M(42.11M)(129.81M)
Capital Expenditures(46.94M)(42.94M)(28.02M)(39.85M)(45.17M)
Acquisitions (Net)88.4M15.8M(30.19M)(71.01M)(15.49M)
Purchases of Investments00(325.83M)0(3.45M)
Sales of Investments000285.75M0
Other Investing Activities14.2M0000
Investing Cash Flow55.67M(27.14M)(384.04M)174.88M(64.11M)
Debt Repayment56.22M(149.85M)(76.96M)(110.24M)(31.89M)
Common Stock Issued123.99M330.91M174.56M11.74M221.18M
Common Stock Repurchased00(1.6M)00
Dividends Paid00000
Other Financing Activities(30.13M)(19.46M)(1.5M)(3.95M)(6.1M)
Financing Cash Flow150.09M161.6M94.5M(102.45M)183.2M
Effect of Forex Changes321.14M(2.47M)(3M)(748.05K)1.56M
Net Change in Cash472.9M(91.46M)(281.89M)29.58M(9.16M)
Free Cash Flow(100.93M)(266.39M)(17.37M)(81.96M)(174.98M)

Tilray Brands, Inc.

NASDAQ:TLRY

Intrinsic Alpha fair value

Locked

Current Price

$2.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.